# Varex Imaging Corp: overview

VREX · Nasdaq · CIK 1681622 · [Technology](/sectors/technology.md) · fiscal year ends Oct 2

Pages: [Overview](/companies/vrex.md) · [Financials](/companies/vrex/financials.md) · [Filings](/companies/vrex/filings.md) · [Insiders](/companies/vrex/insiders.md)

Latest reported revenue: [$210.5m](/filings/0001681622-26-000063.md) for Q3 FY2026, three months to 2026-07-03, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001681622-26-000063).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2025-01-03) | Q2 FY2025 (2025-04-04) | Q3 FY2025 (2025-07-04) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [206 d](/filings/0001681622-25-000108.md) | [200](/filings/0001681622-26-000016.md) | [213](/filings/0001681622-26-000052.md) | [203](/filings/0001681622-26-000063.md) | [229 d](/filings/0001681622-25-000108.md) | [210](/filings/0001681622-26-000016.md) | [216](/filings/0001681622-26-000052.md) | [211](/filings/0001681622-26-000063.md) |
| Gross margin | % | [32.6% d](/filings/0001681622-25-000108.md) | [34.3%](/filings/0001681622-26-000016.md) | [36.0%](/filings/0001681622-26-000052.md) | [33.3%](/filings/0001681622-26-000063.md) | [34.0% d](/filings/0001681622-25-000108.md) | [33.3%](/filings/0001681622-26-000016.md) | [33.6%](/filings/0001681622-26-000052.md) | [36.4%](/filings/0001681622-26-000063.md) |
| Operating margin | % | [5.3% d](/filings/0001681622-25-000108.md) | [5.6%](/filings/0001681622-26-000016.md) | [10.4%](/filings/0001681622-26-000052.md) | [(39.8%)](/filings/0001681622-26-000063.md) | [8.6% d](/filings/0001681622-25-000108.md) | [7.3%](/filings/0001681622-26-000016.md) | [6.7%](/filings/0001681622-26-000052.md) | [10.8%](/filings/0001681622-26-000063.md) |
| Net margin | % | [(24.8%) d](/filings/0001681622-25-000108.md) | [(0.2%)](/filings/0001681622-26-000016.md) | [3.2%](/filings/0001681622-26-000052.md) | [(43.9%)](/filings/0001681622-26-000063.md) | [5.3% d](/filings/0001681622-25-000108.md) | [1.1%](/filings/0001681622-26-000016.md) | [(3.8%)](/filings/0001681622-26-000052.md) | [7.5%](/filings/0001681622-26-000063.md) |
| Diluted EPS | $ per share | not reported | [(0.01)](/filings/0001681622-26-000016.md) | [0.17](/filings/0001681622-26-000052.md) | [(2.15)](/filings/0001681622-26-000063.md) | not reported | [0.05](/filings/0001681622-26-000016.md) | [(0.19)](/filings/0001681622-26-000052.md) | [0.37](/filings/0001681622-26-000063.md) |
| Free cash flow | $m | [19.9 d](/filings/0001681622-25-000108.md) | [5.3](/filings/0001681622-26-000016.md) | [9.8 d](/filings/0001681622-26-000052.md) | [1.4 d](/filings/0001681622-26-000063.md) | [2.3 d](/filings/0001681622-25-000108.md) | [(26.8)](/filings/0001681622-26-000016.md) | [(7.7) d](/filings/0001681622-26-000052.md) | [12.0 d](/filings/0001681622-26-000063.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-10-01) | FY2022 (2022-09-30) | FY2023 (2023-09-29) | FY2024 (2024-09-27) | FY2025 (2025-10-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [818](/filings/0001681622-23-000074.md) | [859](/filings/0001681622-24-000089.md) | [893](/filings/0001681622-25-000108.md) | [811](/filings/0001681622-25-000108.md) | [845](/filings/0001681622-25-000108.md) |
| Gross margin | % | [33.2%](/filings/0001681622-23-000074.md) | [33.0%](/filings/0001681622-24-000089.md) | [32.5%](/filings/0001681622-25-000108.md) | [31.7%](/filings/0001681622-25-000108.md) | [34.4%](/filings/0001681622-25-000108.md) |
| Operating margin | % | [9.1%](/filings/0001681622-23-000074.md) | [10.3%](/filings/0001681622-24-000089.md) | [8.6%](/filings/0001681622-25-000108.md) | [4.0%](/filings/0001681622-25-000108.md) | [(3.3%)](/filings/0001681622-25-000108.md) |
| Net margin | % | [2.1%](/filings/0001681622-23-000074.md) | [3.5%](/filings/0001681622-24-000089.md) | [5.3%](/filings/0001681622-25-000108.md) | [(6.0%)](/filings/0001681622-25-000108.md) | [(8.3%)](/filings/0001681622-25-000108.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001681622-23-000074.md) | [0.73](/filings/0001681622-24-000089.md) | [1.07](/filings/0001681622-25-000108.md) | [(1.20)](/filings/0001681622-25-000108.md) | [(1.70)](/filings/0001681622-25-000108.md) |
| Free cash flow | $m | [77.5](/filings/0001681622-23-000074.md) | [(4.4)](/filings/0001681622-24-000089.md) | [87.7](/filings/0001681622-25-000108.md) | [20.4](/filings/0001681622-25-000108.md) | [18.8](/filings/0001681622-25-000108.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vrex/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $45.3m | 4,344,381 |  | Added +352,101 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $40.6m | 3,894,891 |  | Added +77,061 |
| [Allspring Global Investments Holdings, LLC](/funds/1890906.md) | 2026-06-30 | $24.4m | 2,283,986 |  | Reduced −363,277 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $21.7m | 2,082,597 |  | Added +157,648 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $19.5m | 1,867,162 |  | Added +46,826 |
| [RICE HALL JAMES & ASSOCIATES, LLC](/funds/1230765.md) | 2026-06-30 | $15.1m | 1,445,853 |  | Added +171,035 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $11.6m | 1,116,509 |  | Added +50,200 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $11.5m | 1,097,969 |  | Added +57,740 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $10.5m | 1,007,886 |  | Reduced −549,891 |
| [COOKE & BIELER LP](/funds/24386.md) | 2026-06-30 | $10.4m | 999,151 |  | Reduced −303,861 |

## Recent filings

[All 534 filings](/companies/vrex/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:06 ET | [8-K/A](/filings/0001681622-26-000080.md) | 5.07 Shareholder vote results | 0001681622-26-000080 |
| 2026-10-29 | 09:11 ET | [8-K](/filings/0001681622-26-000077.md) | 5.07 Shareholder vote results | 0001681622-26-000077 |
| 2026-10-22 | 06:31 ET | [8-K](/filings/0001104659-26-117962.md) | 8.01 Other events | 0001104659-26-117962 |
| 2026-08-10 | 16:51 ET | [10-Q](/filings/0001681622-26-000063.md) | Quarterly report, period 2026-07-03 | 0001681622-26-000063 |
| 2026-08-10 | 16:05 ET | [8-K](/filings/0001104659-26-093349.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-093349 |
| 2026-08-10 | 07:32 ET | [8-K](/filings/0001104659-26-093036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093036 |
| 2026-05-07 | 16:22 ET | [10-Q](/filings/0001681622-26-000052.md) | Quarterly report, period 2026-04-03 | 0001681622-26-000052 |
| 2026-05-07 | 16:11 ET | [8-K](/filings/0001681622-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001681622-26-000051 |
| 2026-03-16 | 08:31 ET | [8-K](/filings/0001681622-26-000035.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001681622-26-000035 |
| 2026-02-13 | 16:09 ET | [8-K](/filings/0001681622-26-000031.md) | 5.07 Shareholder vote results | 0001681622-26-000031 |

## Latest annual report

[Form 10-K for the fiscal year ended Oct 3, 2025](/filings/0001681622-25-000108.md), filed Nov 18, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1681622
- Tickers: VREX
- Exchange: Nasdaq
- SIC code: 3679 Electronic Components, NEC
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:09 ET. No prices; not investment advice.